CeriBell, Inc. (CBLL): Rasio utang jangka cendhak marang ekuitas

CeriBell - logo grafis emiten CBLL

This CeriBell, Inc. (CBLL) trading chart shows a metric at 0.00. Business revenues are growing through the sale of consumables, gradually capturing the hospital sector. The brand's high status in emergency therapy is confirmed by the success of its cloud-based EEG monitoring. The application of artificial intelligence in brain activity diagnostics minimizes operational risks, enabling the rapid detection of occult seizures.

Rasio tanggungan utang jangka cendhak marang modal CeriBell Corp (CBLL): kanggo periode 12.10.2024 - 28.10.2026
Sampel barang ceribell.com

Scaling cloud AI platforms for EEG monitoring in hospitals creates significant operational leverage for CeriBell, Inc. (CBLL). This indicator compares obligations due within one year to the market value of equity, assessing refinancing risks during cycle shifts. By analyzing the historical ratio of short-term loans to equity, an investor can discern the balance between financial stability and borrowing efficiency. Low debt leverage confirms price strength amid business expansion.

Analisis perusahaan pesaing

Biogen Corp - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Neurocrine Corp NBIX|Rasio utang jangka cendhak marang ekuitas RGC (Regencell Bioscience)|axsome.com - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas ACADIA Pharmaceuticals Inc. (ACAD)|XENE: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas VKTX|Supernus Corp (SUPN) - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal CPRX|Rasio utang jangka cendhak marang ekuitas denalitherapeutics.com|Harmony Biosciences Holdings, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal BHVN (Biohaven Ltd)|Utang jangka cendhak marang ekuitas Amylyx|Rasio tanggungan utang jangka cendhak marang modal Trevi Corp TRVI|Utang jangka cendhak marang modal PRAX (Praxis Precision Medicines)|AVXL - Koefisien utang jangka cendhak marang modal|Prothena Corp (PRTA) - Utang jangka cendhak marang modal|Alector (ALEC) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal ANNX (Annexon Inc.)|Kewajiban jangka cendhak marang modal OMER|Utang jangka cendhak marang ekuitas Neurogene Inc. (NGNE)|Utang jangka cendhak marang ekuitas ACIU (acimmune.com)|Utang jangka cendhak marang ekuitas Voyager Therapeutics, Inc. VYGR|NMRA - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Scilex Holding Co. (SCLX)|TVGN - Rasio tanggungan utang jangka cendhak marang modal|alphacognition.com - Utang jangka cendhak marang modal|CGTX (cogrx.com) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Inhibikase Therapeutics, Inc. (IKT)|Rasio utang jangka cendhak marang modal Cassava Sciences Inc|Utang jangka cendhak marang modal ASRT (Assertio Holdings, Inc.)|Rasio utang jangka cendhak marang ekuitas coyatherapeutics.com COYA|Rasio utang jangka cendhak marang ekuitas VTGN|Koefisien utang jangka cendhak marang modal Ovid Therapeutics Inc OVID|ABOS: Utang jangka cendhak marang modal|CRVO - Rasio utang jangka cendhak marang ekuitas|alteritytherapeutics.com (ATHE) - Utang jangka cendhak marang modal|CLNN (Clene) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas PepGen Inc|Utang jangka cendhak marang ekuitas JUNS|Utang jangka cendhak marang ekuitas Relmada Therapeutics, Inc. (RLMD)|Utang jangka cendhak marang ekuitas ANVS (Annovis Bio Inc)|GRCE - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal Firefly Neuro AIFF|KLTO (ANEW Medical, Inc.) - Utang jangka cendhak marang modal|NeuroSense Therapeutics (NRSN) - Kewajiban jangka cendhak marang modal|RVPH: Rasio utang jangka cendhak marang ekuitas|MTVA (MetaVia) - Utang jangka cendhak marang modal|NRXS - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal HSDT|Passage Bio, Inc. - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal bionomics.com.au (NEUP)|Minerva Neurosciences, Inc. - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Athira Pharma Inc ATHA|ADXN (Addex Therapeutics, Ltd.) - Utang jangka cendhak marang modal|ALZN: Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas cyclerion.com CYCN|Protagenic Therapeutics, Inc. (PTIX) - Rasio tanggungan utang jangka cendhak marang modal|KTTA: Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Cortigent Medical|Utang jangka cendhak marang modal Avenue Therapeutics, Inc (ATXI)|Utang jangka cendhak marang ekuitas BrainStorm Cell Therapeutics Inc. (BCLI)|CARA: Utang jangka cendhak marang modal|chromocell.com - Kewajiban jangka cendhak marang modal|ELYM - Utang jangka cendhak marang ekuitas|ITCI: Utang jangka cendhak marang ekuitas|Longboard Pharma (LBPH) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Marinus Pharma|NKGN - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal neurobopharma.com|SAGE (Sage Therapeutics) - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal SNPX (Synaptogenix Inc.)|TRVN - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal Vigil Neuroscience Inc. VIGL|WENA: Utang jangka cendhak marang modal|cerevel.com (CERE) - Rasio utang jangka cendhak marang ekuitas